elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38325814-132C8549-2BE4-4AC6-8E0B-F07BF672270C
Q38325814-132C8549-2BE4-4AC6-8E0B-F07BF672270C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325814-132C8549-2BE4-4AC6-8E0B-F07BF672270C
Early investigational drugs targeting PPAR-α for the treatment of metabolic disease.
P2860
Q38325814-132C8549-2BE4-4AC6-8E0B-F07BF672270C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325814-132C8549-2BE4-4AC6-8E0B-F07BF672270C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5943224ad4204ab26880fab518dfde263d68f021
P2860
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes